Notably, BRAF and CREB3L2 are both in the KEGG pathway for prostate cancer, thus raising the possibility that PLX4720 may also play a role in interfering with CREB3L2 binding to DNA and impacting transcription, possibly in prostate cancer. The gene discussed is CREB3L2; the disease is prostate cancer.